ARES holder plans 590,000-share Rule 144 sale, $86.98M value

ARES Management has a holder filing a notice to sell common stock under Rule 144.

Rhea-AI Filing Summary

ARES Management has a holder filing a notice to sell common stock under Rule 144. The filing covers a proposed sale of 590,000 common shares through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $86,983,700. The issuer reports 216,852,343 common shares outstanding and the approximate sale date listed is 11/24/2025 on the NYSE.

The seller acquired these shares as founders shares from the issuer on 05/02/2014. The notice also discloses prior Rule 10b5-1 plan sales by Atticus Enterprises LLC, including a sale of 44,760 common shares on 08/25/2025 for gross proceeds of $7,975,820.21. By signing, the seller represents they are not aware of undisclosed material adverse information about ARES.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ARES Form 144 filing disclose about planned share sales?

The Form 144 notice for ARES (ARES) discloses an intended sale of 590,000 common shares through Morgan Stanley Smith Barney LLC on or about 11/24/2025, to be traded on the NYSE, with an aggregate market value of $86,983,700.

How many ARES shares are outstanding according to this Form 144?

The notice states that 216,852,343 common shares of ARES were outstanding at the time referenced in the filing, providing context for the planned Rule 144 sale.

How and when were the ARES shares in this Form 144 originally acquired?

The shares covered by this Form 144 were acquired as founders shares from the issuer on 05/02/2014, with 590,000 common shares reported as acquired on that date.

What prior ARES share sales are disclosed for the past three months?

The filing reports prior Rule 10b5-1 sales for Atticus Enterprises LLC, including a sale of 44,760 ARES common shares on 08/25/2025 for $7,975,820.21 in gross proceeds.

Which broker is handling the proposed ARES share sale under this Form 144?

The proposed sale of 590,000 ARES common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the seller make in the ARES Form 144 filing?

The seller represents that they do not know any material adverse information about the current or prospective operations of ARES that has not been publicly disclosed, and this representation also applies as of the Rule 10b5-1 plan adoption date if such a plan is used.

Is the ARES Form 144 sale related to a trading plan under Rule 10b5-1?

The section on past three months’ sales identifies 10b5-1 sales for Atticus Enterprises LLC, and the signature language describes how representations apply if a written trading plan under Rule 10b5-1 has been adopted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001304471
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARES MANAGEMENT CORPORATION
SEC File Number	001-36429
Address of Issuer	1800 Avenue of the Stars, Suite 1400 Los Angeles CALIFORNIA 90067
Phone	3102014100
Name of Person for Whose Account the Securities are To Be Sold	ATTICUS ENTERPRISES LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	590000	86983700.00	216852343	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2014	Founders Shares	ISSUER			590000	05/02/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ATTICUS ENTERPRISES LLC 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	08/25/2025	44760	7975820.21

144: Remarks and Signature

Remarks
Date of Notice	11/24/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/13/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Arougheti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)